Form 8-K - Current report:
SEC Accession No. 0001193125-26-236820
Filing Date
2026-05-22
Accepted
2026-05-22 16:01:45
Documents
11
Period of Report
2026-05-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d900837d8k.htm   iXBRL 8-K 25300
  Complete submission text file 0001193125-26-236820.txt   143665

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA snse-20260522.xsd EX-101.SCH 3172
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20260522_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20260522_pre.xml EX-101.PRE 11702
14 EXTRACTED XBRL INSTANCE DOCUMENT d900837d8k_htm.xml XML 3745
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 261013530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)